|
?:abstract
|
-
BSACP serves its members by providing a forum for professional development and networking, as well as by raising the profile of the specialty and improving understanding amongst those responsible for abortion-related policy, guidance, commissioning, regulation and training 2 Utility of a routine ultrasound for detection of ectopic pregnancies amongst women requesting abortion: a retrospective review Clara I Duncan1* John J Reynolds-Wright2 Sharon T Cameron2,3 1The Medical School, University of Edinburgh, Edinburgh, UK 2MRC Centre for Reproductive Health, University of Edinburgh, Edinburgh, UK 3Chalmers Centre for Sexual and Reproductive Health, Edinburgh, UK Background Routine ultrasound may be used in abortion services to determine gestational age and confirm an intrauterine pregnancy The value of routine ultrasound in excluding ectopic pregnancy in symptom-free women without significant risk factors is questionable as it may aid detection of some cases but may give false reassurance that a pregnancy is intrauterine 3 Acceptability of early medical abortion delivered by telemedicine – preliminary data from an NHS community abortion service John Reynolds-Wright1* Anne Johnstone2 Karen McCabe3 Claire Nicol4 Sharon Cameron5 1Clinical Research Fellow, MRC Centre for Reproductive Health, University of Edinburgh, Edinburgh, UK 2Clinical Research Nurse, University of Edinburgh, Edinburgh, UK 3Clinical Research Midwife, University of Edinburgh, Edinburgh, UK 4Advanced Sexual and Reproductive Health Practitioner, NHS Lothian, Edinburgh, UK 5Consultant Gynaecologist, NHS Lothian and Honorary Professor of Sexual and Reproductive Health, University of Edinburgh, Edinburgh, UK Introduction In response to the COVID-19 outbreak, the NHS Lothian abortion service (based at the Chalmers Centre for Sexual and Reproductive Health, Edinburgh) transferred wholly to telemedicine delivery of abortion care Continuing to provide the majority of EMA care via telemedicine would appear to be an effective approach, appreciated by patients 4 Do medication abortion complications increase when mifepristone is available without regulations restricting practice? A population-based study using linked health administrative data from Canada Laura Schummers1,2* Elizabeth K Darling2,3 Anastasia Gayowsky2 Sheila Dunn4 Kimberlyn McGrai5 Michael Law5 Tracey-Lea Laba6 Wendy V Norman1,7 1Department of Family Practice, University of British Columbia, Vancouver, Canada 2ICES McMaster, Hamilton, Ontario, Canada 3Department of Obstetrics and Gynecology, McMaster University, Hamilton, Ontario, Canada 4Department of Family and Community Medicine, University of Toronto, Toronto, Canada 5School of Population and Public Health, University of British Columbia, Vancouver, Canada 6Centre for Health Economics Research and Evaluation, University of Technology Sydney, Sydney, Australia 7Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, UK Objective In January 2017, mifepristone became available in Canada, where abortion has been fully decriminalised since 1988
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}